文献速递胃肠外科急腹症与外科感染围术期管理与 ERAS

急性憩室炎Hartmann术后造口还纳:单中心回顾性研究

Stoma reversal after Hartmann's procedure for acute diverticulitis.
PubMed 文献 · Surgery · 2022-12-12

本研究回顾性分析2006至2017年因急性憩室炎行急诊Hartmann术的218例患者,随访至2021年3月。2年内45.9%完成造口还纳,34.9%带造口死亡,19.3%带造口存活;还纳术后90天死亡率为0%,12%发生Clavien-Dindo IIIb-IV级并发症。

要点

  • 急性憩室炎Hartmann术后2年内约半数患者完成造口还纳。
  • 未还纳的主要原因为患者拒绝手术(41%)和痴呆(23%)。
  • 还纳手术安全性可接受,90天死亡率为0%。

核心结论

  • 急性憩室炎行Hartmann术后,约三分之一患者死亡,半数完成造口还纳,五分之一在2年内未还纳。
  • 带造口存活者多因不愿手术或严重合并症无法择期手术。
  • Hartmann术仍是高危穿孔性急性憩室炎患者的可行选择。

研究设计与样本

  • 单中心回顾性研究,纳入2006至2017年因急性憩室炎行急诊Hartmann术的患者,随访至2021年3月。
  • 共筛查2932例患者的3319次憩室炎发作,最终218例接受Hartmann术。

主要发现

  • 218例中157例(72%)有腹膜炎,其中48例(22%)伴器官功能障碍。
  • 2年内76例(34.9%)带造口死亡,42例(19.3%)带造口存活,100例(45.9%)完成造口还纳。
  • 还纳组与未还纳组1年生存率分别为100%和42.7%,2年分别为96.0%和35.0%,5年分别为88.9%和20.7%。
  • 未还纳的危险因素包括高龄、需要外部协助、低Helsinki急性憩室炎分期评分及入院时较高C反应蛋白水平。
  • 存活患者未还纳最常见原因为患者不愿手术18例(41%)和痴呆10例(23%)。

临床怎么用

  • 对于高危穿孔性急性憩室炎患者,Hartmann术仍可作为可行术式。
  • 术前应与患者及家属充分沟通造口还纳的可能性及拒绝还纳的原因。
  • 对存活带造口患者,需评估合并症及患者意愿以决定是否行还纳手术。

局限性

  • 单中心回顾性研究,可能存在选择偏倚和信息偏倚。
  • 样本量有限,部分亚组分析效能不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hartmann's procedure is a treatment option for perforated acute diverticulitis, especially when organ dysfunction(s) are present. Its use has been criticized mostly out of fear of high permanent stoma rate. The aim of this study was to investigate the rate of stoma reversal, reasons behind nonreversal, and safety of reversal surgery. METHODS: This was a single-center retrospective study of patients undergoing urgent Hartmann's procedure due to acute diverticulitis between the years 2006 and 2017 with follow-up until March 2021. RESULTS: A total of 3,319 episodes of diverticulitis in 2,932 patients were screened. The Hartmann's procedure was performed on 218 patients, of whom 157 (72%) had peritonitis (48 (22%) with organ dysfunction). At 2-years, 76 (34.9%) patients had died with stoma, 42 (19.3%) were alive with stoma, and 100 (45.9%) had undergone stoma reversal. The survival of patients with and without reversal were 100% and 42.7% at 1-year, 96.0% and 35.0% at 2-years and 88.9% and 20.7% at 5-years, respectively. The risk factors for nonreversal were old age, a need for outside assistance, low HElsinki Staging for Acute Diverticulitis stage, and higher C-reactive protein level upon hospital admission. The most common reasons for nonreversal in surviving patients were patient not willing to have the operation 18 (41%) and dementia 10 (23%). Twelve (12%) patients had a major complication after reversal (Clavien-Dindo IIIb-IV) and 90-day mortality after reversal was 0%. CONCLUSION: After the Hartmann's procedure for acute diverticulitis, one-third died, half underwent stoma reversal, and one-fifth did not undergo stoma reversal within 2 years. Patients who survive with stoma are either not willing to have reversal or have severe comorbidities excluding elective surgery. The Hartmann's procedure remains a viable option for high-risk patients with perforated acute diverticulitis.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Salusjärvi JM, Koskenvuo LE, Mali JP, et al. Stoma reversal after Hartmann's procedure for acute diverticulitis. Surgery. 2022. PMID: 36517294. doi:10.1016/j.surg.2022.10.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。